<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04920227</url>
  </required_header>
  <id_info>
    <org_study_id>2020-528</org_study_id>
    <nct_id>NCT04920227</nct_id>
  </id_info>
  <brief_title>Comparation of CLASS Combined With Phacoemulsification and CLASS Alone in the Treatment of Primary Open Angle Glaucoma</brief_title>
  <official_title>Comparation of CO2 Laser-Assisted Sclerectomy Surgery Combined With Phacoemulsification and CO2 Laser-Assisted Sclerectomy Surgery Alone in the Treatment of Primary Open Angle Glaucoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Second Affiliated Hospital, School of Medicine, Zhejiang University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the effect of intraocular pressure control and the incidence of peripheral&#xD;
      anterior synechia between CLASS combined with phacoemulsification and CLASS alone in the&#xD;
      treatment of primary open-angle glaucoma&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Group A: CO2 Laser-Assisted Sclerectomy Surgery combined with phacoemulsification; Group B:&#xD;
      simple CO2 Laser-Assisted Sclerectomy Surgery. The patients were followed up for 1 year. The&#xD;
      incidence of peripheral anterior synechia and Intraocular pressure changes at 1 day, 1 week,&#xD;
      1 month, 2 months, 3 months, 6 months and 12 months were observed and compared between the&#xD;
      two groups.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 2, 2020</start_date>
  <completion_date type="Anticipated">August 2023</completion_date>
  <primary_completion_date type="Anticipated">August 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of peripheral anterior synechia</measure>
    <time_frame>1 year</time_frame>
    <description>Incidence of peripheral anterior synechia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intraocular pressure</measure>
    <time_frame>1 year</time_frame>
    <description>Intraocular pressure</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Glaucoma, Open-Angle</condition>
  <arm_group>
    <arm_group_label>CLASS+PHACO</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CO2 Laser-Assisted Sclerectomy Surgery combined with phacoemulsification</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CLASS</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>CO2 Laser-Assisted Sclerectomy Surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>phacoemulsification;</intervention_name>
    <description>Group A: class combined with phacoemulsification</description>
    <arm_group_label>CLASS+PHACO</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Primary open-angle glaucoma patients with cataract in our Ophthalmic Center;&#xD;
&#xD;
          -  Topical use of hypotensive drugs in the treatment of poor or intolerable intraocular&#xD;
             pressure control;&#xD;
&#xD;
          -  The patients were aged from 50 to 80 years old, regardless of gender;&#xD;
&#xD;
          -  Class operation and phacoemulsification were performed;&#xD;
&#xD;
          -  Patients are able and willing to comply with the research guidance and may complete&#xD;
             all visits required by the research;&#xD;
&#xD;
          -  Informed consent has been signed.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Allergic to any perioperative medication in this study;&#xD;
&#xD;
          -  History of ocular trauma;&#xD;
&#xD;
          -  Any previous intraocular surgery;&#xD;
&#xD;
          -  Angle of the chamber was narrow by angle microscopy (Schaffer grade III and below);&#xD;
&#xD;
          -  Patients diagnosed as secondary glaucoma;&#xD;
&#xD;
          -  Optic atrophy caused by other reasons;&#xD;
&#xD;
          -  The serious complications such as posterior capsule rupture and choroidal hemorrhage&#xD;
             occurred during the operation;&#xD;
&#xD;
          -  Serious complications of eyes occurred after operation;&#xD;
&#xD;
          -  The patient's history indicated that he had severe dysfunction of heart, lung, liver&#xD;
             and kidney;&#xD;
&#xD;
          -  Women in pregnancy, lactation or planned pregnancy;&#xD;
&#xD;
          -  The researchers believe that the patient's condition may put the patient at&#xD;
             significant risk, and may confuse the research results.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kaijun Wang, MD</last_name>
    <role>Study Director</role>
    <affiliation>Eye Center, the 2nd Affiliated Hospital, Medical College of Zhejiang University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kaijun Wang, MD</last_name>
    <phone>+86 0571 87783759</phone>
    <email>wkj992@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Eye Center, the 2nd Affiliated Hospital, Medical College of Zhejiang University</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kaijun Wang, MD</last_name>
      <phone>+86 0571 87783759</phone>
      <email>wkj992@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>June 1, 2021</study_first_submitted>
  <study_first_submitted_qc>June 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 9, 2021</study_first_posted>
  <last_update_submitted>June 4, 2021</last_update_submitted>
  <last_update_submitted_qc>June 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
    <mesh_term>Glaucoma, Open-Angle</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

